{"product_id":"elisa-kit-for-lysophosphatidylcholine-lpc-abcc24618","title":"ELISA Kit for Lysophosphatidylcholine (LPC)","description":"\u003ch4\u003eFormat\u003c\/h4\u003e\u003cp\u003e48T, \u003ci\u003e96T\u003c\/i\u003e, 96T×5, 96T×10, 96T×100\u003c\/p\u003e\u003ch4\u003eDetection range\u003c\/h4\u003e\u003cp\u003e246.9-20,000ng\/mL\u003c\/p\u003e\u003ch4\u003eApplication\u003c\/h4\u003e\u003cp\u003eEnzyme-linked immunosorbent assay for Antigen Detection.\u003c\/p\u003e\u003ch4\u003eOrganism species\u003c\/h4\u003e\u003cp\u003ePan-species (General)\u003c\/p\u003e\u003ch4\u003eSensitivity\u003c\/h4\u003e\u003cp\u003eThe minimum detectable dose of this kit is typically less than 92.4ng\/mL\u003c\/p\u003e\u003ch4\u003eSample type\u003c\/h4\u003e\u003cp\u003eSerum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids\u003c\/p\u003e\u003ch4\u003eAssay length\u003c\/h4\u003e\u003cp\u003e2h\u003c\/p\u003e\u003ch4\u003eMethod\u003c\/h4\u003e\u003cp\u003eCompetitive Inhibition\u003c\/p\u003e\u003ch4\u003eTest principle\u003c\/h4\u003e\u003cp\u003eThis assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Lysophosphatidylcholine (LPC) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin labeled Lysophosphatidylcholine (LPC) and unlabeled Lysophosphatidylcholine (LPC) (Standards or samples) with the pre-coated antibody specific to Lysophosphatidylcholine (LPC). After incubation the unbound conjugate is washed off. Next, avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. The amount of bound HRP conjugate is reverse proportional to the concentration of Lysophosphatidylcholine (LPC) in the sample. After addition of the substrate solution, the intensity of color developed is reverse proportional to the concentration of Lysophosphatidylcholine (LPC) in the sample.\u003c\/p\u003e\u003ch4\u003eAlternative Names\u003c\/h4\u003e\u003cp\u003elysoPC; Lysolecithin; 1-Palmitoyl-sn-Glycero-3-Phosphocholine \u003c\/p\u003e\u003ch4\u003eItem Name\u003c\/h4\u003e\u003cp\u003eLysophosphatidylcholine\u003c\/p\u003e\u003ch4\u003eResearch Area\u003c\/h4\u003e\u003cp\u003e\u003c\/p\u003e\u003ch4\u003eReference\u003c\/h4\u003e\u003cp\u003e\u003ca href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28811491\"\u003eHigh-fat diet-induced acceleration of osteoarthritis is associated with a distinct and sustained plasma metabolite signature\u003c\/a\u003e;\u003ca href=\"https:\/\/stemcellsjournals.onlinelibrary.wiley.com\/doi\/abs\/10.1002\/stem.2967\"\u003eIron Homeostasis Determines Fate of Human Pluripotent Stem Cells Via Glycerophospholipids‐Epigenetic Circuit\u003c\/a\u003e;\u003ca href=\"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-019-1040-5\"\u003eAssociations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy\u003c\/a\u003e;\u003ca href=\"https:\/\/www.nature.com\/articles\/s41467-019-11274-x\"\u003eER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy\u003c\/a\u003e;\u003c\/p\u003e","brand":"ABCbiolab","offers":[{"title":"96T \/ The minimum detectable dose of this kit is typically less than 92.4ng\/mL \/ Pan-species (General)","offer_id":42481701290218,"sku":"ABCC24618","price":816.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0590\/5652\/1400\/products\/74120318_padded_logo_c1ef8873-7c9b-4444-8e44-9306129b716b.png?v=1644865394","url":"https:\/\/danabiosci.com\/products\/elisa-kit-for-lysophosphatidylcholine-lpc-abcc24618","provider":"Dana Bioscience","version":"1.0","type":"link"}